ArticleTheranostics2022

Therapeutic aptamer targeting sclerostin loop3 for promoting bone formation without increasing cardiovascular risk in osteogenesis imperfecta mice.

Luyao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.